TI
ABMD

Tidal Investments’s Abiomed Inc ABMD Stock Holding History

Tidal Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,783
Closed -$684K – 1255
2022
Q3 		$684K Buy
2,783
+84
+3% +$22.7K 0.03% 467
2022
Q2 		$668K Buy
2,699
+588
+28% +$159K 0.02% 498
2022
Q1 		$699K Sell
2,111
-417
-16% -$128K 0.02% 548
2021
Q4 		$908K Buy
2,528
+331
+15% +$112K 0.03% 435
2021
Q3 		$721K Buy
+2,197
New +$744K 0.03% 416

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tidal Investments's ABMD Position: Q4 2022 in Review

Tidal Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,783 shares — an estimated $684K sold.

Tidal Investments first reported a position in ABMD in Q3 2021 and held it in 5 quarters. The position peaked at $908K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Tidal Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Tidal Investments sold 2,783 Abiomed Inc shares in Q4 2022, an estimated $684K.
  • Tidal Investments first reported a position in Abiomed Inc in Q3 2021 and held it in 5 quarters.
  • Tidal Investments's Abiomed Inc position peaked at $908K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Tidal Investments's 13F filing for Q4 2022, filed 15 Feb 2023.